Nonalcoholic fatty liver disease and microvascular complications in type 2 diabetes

Ítems similars

• Comparison of a Multiple Daily Insulin Injection Regimen (Glargine or Detemir Once Daily Plus Prandial Insulin Aspart) and Continuous Subcutaneous Insulin Infusion (Aspart) in Short-Term Intensive Insulin Therapy for Poorly Controlled Type 2 Diabetes Patients
  per: Lv, Wen-shan, et al.
  Publicat: (2013)
• Comparison of a Multiple Daily Insulin Injection Regimen (Glargine or Detemir Once Daily Plus Prandial Insulin Aspart) and Continuous Subcutaneous Insulin Infusion (Aspart) in Short-Term Intensive Insulin Therapy for Poorly Controlled Type 2 Diabetes Patients
  per: Wen-shan Lv, et al.
  Publicat: (2013-01-01)
• Association between UCP3 gene polymorphisms and nonalcoholic fatty liver disease in Chinese children
  per: Xu, Yan-Ping, et al.
  Publicat: (2013)
• Herbal drug discovery for the treatment of nonalcoholic fatty liver disease
  per: Tingting Yan, et al.
  Publicat: (2020-01-01)
• Herbal drug discovery for the treatment of nonalcoholic fatty liver disease
  per: Yan, Tingting, et al.
  Publicat: (2020)